Deerwalk Releases Opioid Impact Report and Breast Cancer Treatment Path Report in Plan Analytics Version 7.9

Posted by Deerwalk Engineering Team on August 09, 2018

Deerwalk is proud to announce enhanced features of Plan Analytics, the flagship population health analytics and reporting application, with version 7.9 released earlier this week. The release is available immediately and includes two new reports; the Opioid Impact report and the Breast Cancer Treatment Path report.

Opioid misuse and abuse can be both costly and damaging to patient health. The new Opioid Impact report measures the prevalence of opioid overuse warning signs and risk indicators and quantifies the financial impact of opioids on plan spending.



The Breast Cancer Treatment Path report is a narrative walk through of care quality indicators for breast cancer patients. Deerwalk released this report in response to exciting new research on best practices and the necessity of chemotherapy. You can read more about the context for this report from the New York Times.


Customers seeking more information on Plan Analytics Release 7.9 should contact their account managers.

To contact a Deerwalk representative to learn more about our analytics solutions and schedule a demo, click below.


Subscribe to our blog, facebook, twitter or LinkedIn page to join the conversation and tell us what you think.